NOVEL OXALYL PIPERAZINES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)
本页收录老挝专利「NOVEL OXALYL PIPERAZINES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)」的公开登记要点,由 AiCuris GmbH & Co.KG 于 2020-04-29 提交申请,当前状态为等待形式审查。标识字段包括:申请号 P/806;DIP 编号 LAP806;主管局代码 LA;保护类型 Patent - PCT National Phase。时间线要点:公开/公告日 2026-01-30。技术或外观分类记载为 A61K 31/496、C07D 403/06。发明人 / 设计人包括 BARRIOS, Esther Alza、BONSMANN, Susanne、DETTA, Elena、DONALD, Alastair、GOLDNER, Thomas 等。代理机构 / 代理人记载为 Lao Trademark Agency。公开摘要提示:The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhib…。
The following summary describes a Laos patent titled “NOVEL OXALYL PIPERAZINES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)”, filed by AiCuris GmbH & Co.KG on 2020-04-29; current status: Awaiting formal examination. Identifiers include application No. P/806; DIP id LAP806; protection kind Patent - PCT National Phase. Key dates: publication 2026-01-30. Classification: A61K 31/496、C07D 403/06. Inventor(s)/designer(s): BARRIOS, Esther Alza, BONSMANN, Susanne, DETTA, Elena, DONALD, Alastair, GOLDNER, Thomas. Abstract hint: The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhib…. Status labels may change after office actions; refresh or consult primary DIP data before commercial decisions.
ສິດທິບັດ «NOVEL OXALYL PIPERAZINES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)» ເປັນຂໍ້ມູນຊັບສິນທາງປັນຍາເປີດເຜີຍຂອງ DIP, ຍື່ນໂດຍ AiCuris GmbH & Co.KG ໃນວັນທີ 2020-04-29; ສະຖານະ ລໍຖ້າກວດຮູບແບບ. ຕົວລະບຸ: ເລກທີຄຳຮ້ອງ P/806; ລະຫັດ DIP LAP806; ປະເພດການປົກປ້ອງ Patent - PCT National Phase. ວັນທີສຳຄັນ: ວັນເຜີຍແຜ່ 2026-01-30. ປະເພດ/ຫ້ອງ: A61K 31/496、C07D 403/06. ນັກປະດິດ/ນັກອອກແບບ: BARRIOS, Esther Alza, BONSMANN, Susanne, DETTA, Elena, DONALD, Alastair, GOLDNER, Thomas. ສະຫຼຸບ: The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhib…. ຂໍ້ມູນເພື່ອອ້າງອີງເທົ່ານັ້ນ ບໍ່ແມ່ນຄຳແນະນຳທາງກົດໝາຍ ຫຼື ໃບຢັ້ງຢືນສິດ.
P/806
图样
基础信息
- 类型
- 专利
- 申请号
P/806- 状态
- 等待形式审查
- 申请人
- AiCuris GmbH & Co.KG
- 代理机构
- Lao Trademark Agency
- 申请日期
- 2020-04-29
- 公开/公告日
- 2026-01-30
- 国际分类
- A61K 31/496 · C07D 403/06
- 商品 / 服务
- —
办理流程
根据当前状态动态标注-
提交申请
-
形式审查 进行中
-
实质审查
-
公开
-
授权
关联分析
LaoBiz 企业数据库联动类似专利推荐
摘要
The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.
The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.